Clinical benefit of continuing crizotinib beyond initial disease progression in patients with advanced ALK-positive non-small-cell lung cancer Meeting Abstract
| Authors: | Ou, S. H. I.; Riely, G. J.; Tang, Y. Y.; Kim, D. W.; Otterson, G. A.; Crino, L.; Bartlett, C. H.; Cohen, D. P.; Clark, J. W.; Jänne, P. A. |
| Abstract Title: | Clinical benefit of continuing crizotinib beyond initial disease progression in patients with advanced ALK-positive non-small-cell lung cancer |
| Meeting Title: | 15th World Conference on Lung Cancer (IASLC) |
| Keywords: | oncogene; tki; addiction; crizotinib; treatment beyond disease progression |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 8 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2013 Oct 27-31 |
| Meeting Location: | Sydney, Australia |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2013-11-01 |
| Start Page: | S294 |
| Language: | English |
| ACCESSION: | WOS:000339624901134 |
| PROVIDER: | wos |
| DOI: | 10.1097/01.JTO.0000438438.14562.c8 |
| Notes: | Meeting Abstract: MO07.01 -- Source: Wos |
